Another peer-reviewed study based on passive surveillance from Ontario, Canada, found that the rate of myocarditis was greater in younger males than females, and also greater after the second dose than the first dose of an mRNA vaccine.
On June 17, the U.S. Food and Drug Administration (FDA) granted emergency use authorization (EUA) for Moderna and Pfizer vaccines for children as young as 6 months old.
